Literature DB >> 10793869

Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden.

J A Kanis1, O Johnell, A Oden, B Jonsson, A Dawson, W Dere.   

Abstract

Bone mineral density measurements are widely used to estimate the relative risk of hip fracture. In addition, many other risk factors have been identified, some of which are known to add to the risk independently of other risk factors, including bone mineral density measurements. In this paper we develop an algorithm that converts relative risks for hip fracture to absolute (15 years and lifetime) risks, modeled on the population of Sweden. Lifetime risks increased as expected with increments in relative risk. Average lifetime risk in women at the age of 50 years was 22.7%, which increased to 64.9% when the relative risk was 6.0. In men the risk increased from 11.1% to 41.3%. The identification of high-risk groups had little effect on the specificity of assessments but increased the sensitivity over a wide range of assumptions. The increment in lifetime risk was relatively stable across all ages, reducing the complexity of computing lifetime risks from relative risk. The derivation of absolute risk from relative risk permits the optimization of selection of individuals or populations either for further risk assessment or for treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10793869     DOI: 10.1007/PL00004173

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

1.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

2.  Absolute fracture risk.

Authors:  Chad L Deal
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

Review 3.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

4.  Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Authors:  Fredrik Borgström; Olof Johnell; John A Kanis; Anders Oden; David Sykes; Bengt Jönsson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Incorporating adherence into health economic modelling of osteoporosis.

Authors:  O Ström; F Borgström; J A Kanis; B Jönsson
Journal:  Osteoporos Int       Date:  2008-06-03       Impact factor: 4.507

6.  BMD, clinical risk factors and their combination for hip fracture prevention.

Authors:  H Johansson; J A Kanis; A Oden; O Johnell; E McCloskey
Journal:  Osteoporos Int       Date:  2009-03-17       Impact factor: 4.507

7.  A FRAX® model for the assessment of fracture probability in Belgium.

Authors:  H Johansson; J A Kanis; E V McCloskey; A Odén; J-P Devogelaer; J-M Kaufman; A Neuprez; M Hiligsmann; O Bruyere; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-30       Impact factor: 4.507

8.  T-plus Z-score in the assessment of relative fracture risk.

Authors:  Jaroslava Wendlová
Journal:  Wien Med Wochenschr       Date:  2007

9.  Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study.

Authors:  Daniel Albertsson; Dan Mellström; Christer Petersson; Hans Thulesius; Robert Eggertsen
Journal:  BMC Musculoskelet Disord       Date:  2010-03-24       Impact factor: 2.362

10.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.